Literature DB >> 27987095

Letter to the editor-chronic disseminated candidiasis.

Kenneth Rolston1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27987095     DOI： 10.1007/s00520-016-3546-y

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  8 in total

Review 1.  Hepatosplenic candidiasis. A manifestation of chronic disseminated candidiasis.

Authors:  D P Kontoyiannis; M A Luna; B I Samuels; G P Bodey
Journal:  Infect Dis Clin North Am       Date:  2000-09       Impact factor: 5.982

Review 2.  Polymicrobial bloodstream infections involving Candida species: analysis of patients and review of the literature.

Authors:  Stephen A Klotz; Brian S Chasin; Barbara Powell; Nand K Gaur; Peter N Lipke
Journal:  Diagn Microbiol Infect Dis       Date:  2007-09-20       Impact factor: 2.803

3.  Epidemiology and outcome of multiple-species candidemia at a tertiary care center between 2004 and 2007.

Authors:  Heather L Nace; David Horn; Dionissios Neofytos
Journal:  Diagn Microbiol Infect Dis       Date:  2009-04-18       Impact factor: 2.803

Review 4.  Polymicrobial candidemia.

Authors:  Suzanne Pulimood; Latha Ganesan; George Alangaden; Pranatharthi Chandrasekar
Journal:  Diagn Microbiol Infect Dis       Date:  2002-12       Impact factor: 2.803

5.  Hepatosplenic candidiasis: successful treatment with fluconazole.

Authors:  C A Kauffman; S F Bradley; S C Ross; D R Weber
Journal:  Am J Med       Date:  1991-08       Impact factor: 4.965

6.  Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy.

Authors:  E Anaissie; G P Bodey; H Kantarjian; C David; K Barnett; E Bow; R Defelice; N Downs; T File; G Karam
Journal:  Am J Med       Date:  1991-08       Impact factor: 4.965

7.  An open study on the safety and efficacy of fluconazole in the treatment of disseminated Candida infections in patients treated for hematological malignancy.

Authors:  B E de Pauw; J M Raemaekers; J P Donnelly; B J Kullberg; J F Meis
Journal:  Ann Hematol       Date:  1995-02       Impact factor: 3.673

8.  Successful management of chronic disseminated candidiasis in hematologic patients treated with high-dose liposomal amphotericin B: a retrospective study of the SEIFEM registry.

Authors:  Roberta Della Pepa; M Picardi; F Sorà; M Stamouli; A Busca; A Candoni; M Delia; R Fanci; V Perriello; M Zancanella; A Nosari; P Salutari; F Marchesi; F Pane; L Pagano
Journal:  Support Care Cancer       Date:  2016-04-14       Impact factor: 3.603
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.